Page
%P
2 Result(s)
within
Junsheng Ma
Cancer Research
-
Article
Open AccessPIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer
Personalized and effective treatments for pancreatic ductal adenocarcinoma (PDAC) continue to remain elusive. Novel clinical trial designs that enable continual and rapid evaluation of novel therapeutics are n...
-
Article
Open AccessSimplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations
Gene expression profiling has consistently identified three molecular subtypes of lung adenocarcinoma that have prognostic implications. To facilitate stratification of patients with this disease into similar ...
